Jinglin Zou

机构：East China University of Science and Technology

发表论文 8 篇 · 总被引 159 次 · h-index 4

代表论文

• Tumor microenvironment-responsive engineered hybrid nanomedicine for photodynamic-immunotherapy via multi-pronged amplification of reactive oxygen species (2025 · Nature Communications · 被引 96)
• Ferroptosis and Pyroptosis Co‐Activated Nanomodulator for “Cold” Tumor Immunotherapy and Lung Metastasis Inhibition (2023 · Advanced Functional Materials · 被引 41)
• Engineered Organosilica Hybrid Micelles for Photothermal‐enhanced Starvation Cancer Therapy (2022 · Chemistry - An Asian Journal · 被引 8)
• Inhalable Mucus-Penetrating Engineered Hybrid Nanomedicine for Enhanced Treatment of Idiopathic Pulmonary Fibrosis (2025 · Nano Letters · 被引 3)
• Redox-responsive engineered hybrid nanomedicine for gallbladder cancer therapy via hyaluronic acid depletion (2022 · Applied Materials Today · 被引 3)
• Ionizable mesoporous silica nanoparticle-mediated siAURKB delivery for colorectal cancer therapy (2026 · Journal of Materials Chemistry B · 被引 2)